Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Barclay

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Inflammatory Bowel Diseases|October 24, 2019
A Noninferiority Randomized Clinical Trial of the Use of the Smartphone-Based Health Applications IBDsmart and IBDoc in the Care of Inflammatory Bowel Disease PatientsAndrew McCombie, Russell Walmsley, Murray Barclay, et al.
Clinical and Translational Science|August 25, 2019
Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol ConcentrationLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Inflammatory Bowel Diseases|August 18, 2009
Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitisClaudia Huebner, Brian L Browning, Ivonne Petermann, et al.
Human Immunology|September 20, 2011
Genetic variations in matrix metalloproteinases may be associated with increased risk of ulcerative colitisAngharad R Morgan, Dug-Yeo Han, Wen-Jiun Lam, et al.
Alimentary Pharmacology & Therapeutics|February 20, 2021
Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonatesEmma Flanagan, Emily K Wright, Winita Hardikar, et al.
Therapeutic Drug Monitoring|April 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyDahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, et al.
Nature Genetics|November 25, 2010
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociAndre Franke, Dermot P B McGovern, Jeffrey C Barrett, et al.
Nature Genetics|February 8, 2011
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47Carl A Anderson, Gabrielle Boucher, Charlie W Lees, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Inflammatory Bowel Diseases|October 24, 2019
A Noninferiority Randomized Clinical Trial of the Use of the Smartphone-Based Health Applications IBDsmart and IBDoc in the Care of Inflammatory Bowel Disease PatientsAndrew McCombie, Russell Walmsley, Murray Barclay, et al.
Clinical and Translational Science|August 25, 2019
Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol ConcentrationLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Inflammatory Bowel Diseases|August 18, 2009
Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitisClaudia Huebner, Brian L Browning, Ivonne Petermann, et al.
Human Immunology|September 20, 2011
Genetic variations in matrix metalloproteinases may be associated with increased risk of ulcerative colitisAngharad R Morgan, Dug-Yeo Han, Wen-Jiun Lam, et al.
Alimentary Pharmacology & Therapeutics|February 20, 2021
Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonatesEmma Flanagan, Emily K Wright, Winita Hardikar, et al.
Therapeutic Drug Monitoring|April 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyDahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, et al.
Nature Genetics|November 25, 2010
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociAndre Franke, Dermot P B McGovern, Jeffrey C Barrett, et al.
Nature Genetics|February 8, 2011
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47Carl A Anderson, Gabrielle Boucher, Charlie W Lees, et al.
Pageof 4